Chronic Hepatitis C: A Multifaceted Disease2 CME Credits
Chronic hepatitis C afflicts 170 million individuals worldwide and is a major cause of morbidity and mortality. In this course, we discuss the various modes of acquisition of hepatitis C. Although cirrhosis and its attendant complications including primary hepatocellular carcinoma are the major causes of morbidity and mortality, patients with chronic hepatitis C may also exhibit protean extrahepatic manifestations. On occasion, these dominate the clinical picture and account for serious morbidity and even mortality. Treatment options and definitions of types of responses are clearly delineated.
Fecal Microbiota Transplantation For the Treatment of Recurrent Clostridium Difficile Infections0.5 CME Credit
This course will provide an overview of recurrent clostridium difficile infections, including mechanism of disease and treatment options. This course will also review the steps required for safe fecal microbiota transplantation including: indication, donor, risks, delivery modality, and follow up. This course is intended for clinicians and medical students.
Management of Hyperlipidemia2 CME Credits, 2 MOC Points
Abnormalities in lipid metabolism contribute to increased risk for developing coronary heart disease and other forms of vascular disease. This case-based, multiple question course will review current guidelines for patients with a variety of lipid disorders.
New Drugs to Treat Type 2 Diabetes1.25 CME Credit
New Drugs to Treat Type 2 Diabetes is a case-based review of the newer agents available for the treatment of patients with diabetes. This course focuses on the practical application of these agents for clinicians in practice, including their efficacy, cardiovascular safety and risk/side effect profiles, and when to best consider their use in clinical care.
New Treatments in Heart Failure1 CME Credit
This course provides an update and clinical case discussions on new pharmacologic treatments for heart failure, including angiotensin-neprilysin inhibitors, ivabradine, and iron. This course is intended for advanced care and specialty physicians including cardiologists, primary care physicians, pharmacists, psychologists, physician assistants, nurses, and nurse practitioners.
NOACs for Stroke Prevention in Atrial Fibrillation0.75 CME Credit
This course will review the clinical trial data on the efficacy and safety of non-vitamin K oral anticoagulants (NOACs) for prevention of stroke in patients with atrial fibrillation (AF). We will cover the appropriate dosing and monitoring of NOACs and their appropriate use in different vulnerable patient populations. This course will also review strategies to prevent and manage NOAC-related bleeding in the era of specific reversal agents (antidotes).
Procalcitonin in Diagnosing Bacterial Infection: Ready for Prime-Time?1.25 CME Credit
This course will review the appropriate use and limitations of procalcitonin testing in the diagnosis and antibiotic management of infectious diseases. This course is intended for primary care and specialty physicians, pharmacists, psychologists, physician assistants, nurses, and nurse practitioners.